ArticleJCO precision oncology2024

Sustained Response to Brigatinib in an Aggressive Relapsing Atypical Pituicytoma With ELM4-ALK Fusion.

Pierre-Olivier Moser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.